INTRODUCTION: Erectile dysfunction (ED) is a serious medical condition that affects 16-82% of prostate cancer patients treated by radical prostatectomy and current treatments are ineffective in 50-60% of prostatectomy patients. The reduced efficacy of treatments makes novel therapeutic approaches to treat ED essential. The secreted protein Sonic hedgehog (SHH) is a critical regulator of penile smooth muscle and apoptosis that is decreased in cavernous nerve (CN) injury and diabetic ED models. Past studies using Affi-Gel beads have shown SHH protein to be effective in suppressing apoptosis caused by CN injury. AIM: We hypothesize that SHH protein delivered via novel peptide amphiphile (PA) nanofibers will be effective in suppressing CN injury-induced apoptosis. METHODS: Adult Sprague Dawley rats (n=50) were used to optimize PA injection in vivo. PA with SHH protein (n=16) or bovine serum albumin (BSA) (control, n=14) was injected into adult rats that underwent bilateral CN cut. Rats were sacrificed at 2, 4, and 7 days. Alexa Fluor-labeled SHH protein was used to determine the target of SHH signaling (n=3). MAIN OUTCOME MEASURES: Terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL) and semiquantitative immunohistochemical analysis for SHH protein and cluster differentiation protein three (CD3) were performed. RESULTS: SHH-PA caused a 25% and 16% reduction in apoptosis at 4 and 7 days after CN injury and a 9.3% and 19% increase in SHH protein at 4 and 7 days after CN injury. CD3 protein was not observed in SHH-PA-treated penis. In vitro, 73% of SHH protein diffused from PA within 6 days. Labeled SHH was observed in smooth muscle. CONCLUSIONS: PA technology is effective in delivering SHH protein to the penis and SHH is effective in suppressing CN injury-induced apoptosis. These results suggest substantial translational potential of this methodology and show that only a short duration of SHH treatment is required to impact the apoptotic index.
INTRODUCTION:Erectile dysfunction (ED) is a serious medical condition that affects 16-82% of prostate cancerpatients treated by radical prostatectomy and current treatments are ineffective in 50-60% of prostatectomy patients. The reduced efficacy of treatments makes novel therapeutic approaches to treat ED essential. The secreted protein Sonic hedgehog (SHH) is a critical regulator of penile smooth muscle and apoptosis that is decreased in cavernous nerve (CN) injury and diabetic ED models. Past studies using Affi-Gel beads have shown SHH protein to be effective in suppressing apoptosis caused by CN injury. AIM: We hypothesize that SHH protein delivered via novel peptide amphiphile (PA) nanofibers will be effective in suppressing CN injury-induced apoptosis. METHODS: Adult Sprague Dawley rats (n=50) were used to optimize PA injection in vivo. PA with SHH protein (n=16) or bovineserum albumin (BSA) (control, n=14) was injected into adult rats that underwent bilateral CN cut. Rats were sacrificed at 2, 4, and 7 days. Alexa Fluor-labeled SHH protein was used to determine the target of SHH signaling (n=3). MAIN OUTCOME MEASURES: Terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL) and semiquantitative immunohistochemical analysis for SHH protein and cluster differentiation protein three (CD3) were performed. RESULTS:SHH-PA caused a 25% and 16% reduction in apoptosis at 4 and 7 days after CN injury and a 9.3% and 19% increase in SHH protein at 4 and 7 days after CN injury. CD3 protein was not observed in SHH-PA-treated penis. In vitro, 73% of SHH protein diffused from PA within 6 days. Labeled SHH was observed in smooth muscle. CONCLUSIONS: PA technology is effective in delivering SHH protein to the penis and SHH is effective in suppressing CN injury-induced apoptosis. These results suggest substantial translational potential of this methodology and show that only a short duration of SHH treatment is required to impact the apoptotic index.
Authors: L T Klein; M I Miller; R Buttyan; A J Raffo; M Burchard; G Devris; Y C Cao; C Olsson; R Shabsigh Journal: J Urol Date: 1997-08 Impact factor: 7.450
Authors: Vicki M Tysseling-Mattiace; Vibhu Sahni; Krista L Niece; Derin Birch; Catherine Czeisler; Michael G Fehlings; Samuel I Stupp; John A Kessler Journal: J Neurosci Date: 2008-04-02 Impact factor: 6.167
Authors: Kanya Rajangam; Heather A Behanna; Michael J Hui; Xiaoqiang Han; James F Hulvat; Jon W Lomasney; Samuel I Stupp Journal: Nano Lett Date: 2006-09 Impact factor: 11.189
Authors: Mustafa O Guler; Lorraine Hsu; Stephen Soukasene; Daniel A Harrington; James F Hulvat; Samuel I Stupp Journal: Biomacromolecules Date: 2006-06 Impact factor: 6.988
Authors: Ramille N Shah; Nirav A Shah; Marc M Del Rosario Lim; Caleb Hsieh; Gordon Nuber; Samuel I Stupp Journal: Proc Natl Acad Sci U S A Date: 2010-02-01 Impact factor: 11.205
Authors: Muneera R Kapadia; Lesley W Chow; Nick D Tsihlis; Sadaf S Ahanchi; Jason W Eng; Jozef Murar; Janet Martinez; Daniel A Popowich; Qun Jiang; Joseph A Hrabie; Joseph E Saavedra; Larry K Keefer; James F Hulvat; Samuel I Stupp; Melina R Kibbe Journal: J Vasc Surg Date: 2008-01 Impact factor: 4.268
Authors: Jacqueline J Greene; Mark T McClendon; Nicholas Stephanopoulos; Zaida Álvarez; Samuel I Stupp; Claus-Peter Richter Journal: J Tissue Eng Regen Med Date: 2018-05-16 Impact factor: 3.963
Authors: Shawn Choe; Elizabeth Kalmanek; Christopher Bond; Daniel A Harrington; Samuel I Stupp; Kevin T McVary; Carol A Podlasek Journal: Nanomedicine Date: 2019-06-05 Impact factor: 5.307
Authors: Christopher W Bond; Nicholas Angeloni; Daniel Harrington; Samuel Stupp; Carol A Podlasek Journal: J Sex Med Date: 2012-12-13 Impact factor: 3.802
Authors: Marah Hehemann; Elizabeth Kalmanek; Shawn Choe; Danuta Dynda; Wen-Yang Hu; Marcus L Quek; Daniel A Harrington; Samuel I Stupp; Kevin T McVary; Carol A Podlasek Journal: Neurourol Urodyn Date: 2018-09-06 Impact factor: 2.696